Women's experience with severe overactive bladder symptoms and treatment: insight revealed from patient focus groups.
about
How dry is "OAB-dry"? Perspectives from patients and physician expertsDevelopment of quality indicators for women with urinary incontinence"Seeing a doctor is just like having a date": a qualitative study on doctor shopping among overactive bladder patients in Hong Kong.Misconceptions and miscommunication among Spanish-speaking and English-speaking women with pelvic organ prolapseIncreased fluid intake is associated with bothersome bowel symptoms among women with urinary incontinence.Patients' understanding of pelvic floor disorders: what women want to know.Defining and managing overactive bladder: disagreement among the experts.Antimuscarinic Agent Treatment Affecting Patient-Reported Outcomes in Overactive Bladder Syndrome With Depressive Symptoms.The Michigan Incontinence Symptom Index (M-ISI): a clinical measure for type, severity, and bother related to urinary incontinence.Important role of physicians in addressing psychological aspects of interstitial cystitis/bladder pain syndrome (IC/BPS): a qualitative analysis.The Illness Experiences of Women with Overactive Bladder in Hong Kong.Urinary Incontinence and Health-Seeking Behavior Among White, Black, and Latina Women.Overactive bladder symptom severity, bother, help-seeking behavior, and quality of life in patients with type 2 diabetes: a path analysis.Health literacy, cognition, and urinary incontinence among geriatric inpatients discharged to skilled nursing facilities.Methodology for a trial of brain-centered versus anticholinergic therapy in women with urgency urinary incontinence.Knowledge and attitude for overactive bladder care among women: development and measurement.
P2860
Q24620940-35EF07A0-D688-4BB7-88E9-B2C2DAFFE3C3Q27023541-DA453122-145F-4C63-AA44-9DA42B59FD47Q35087370-5F508D5F-753C-462E-84F3-956B2060FB59Q35998547-96F01B2E-EB8D-4F1D-AF1C-CB6689044C49Q36791979-20D81884-F952-433A-B1B7-6F933A590CC8Q37070788-5740B7B7-7CD2-47B3-A3F5-2FC55F9F9794Q37472682-0FC76812-2DAC-4009-A39E-ACCB353EA1AEQ37553954-9E1DBDAC-F8FF-47EB-A145-91A8FB36D051Q37585803-87E6B977-6FDF-4805-998B-6C07A6E577A8Q37624742-A29B8BF8-038E-4775-A815-F671020AE217Q38563834-C6257B80-FED2-4824-AE9A-39CA548E8782Q40961209-EE1A861E-7A4A-492D-BC98-8E335B88BEE2Q47139604-928BE397-781E-4DA2-B872-162136AA2B33Q47656543-094394C6-9F09-4542-B763-BAB819B3D62EQ48474497-51EF7CDF-D887-4145-A708-E9D3D8AE39C0Q55491661-02C2C105-6111-452A-B3D3-82B66764CB7C
P2860
Women's experience with severe overactive bladder symptoms and treatment: insight revealed from patient focus groups.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Women's experience with severe ...... led from patient focus groups.
@en
Women's experience with severe ...... led from patient focus groups.
@nl
type
label
Women's experience with severe ...... led from patient focus groups.
@en
Women's experience with severe ...... led from patient focus groups.
@nl
prefLabel
Women's experience with severe ...... led from patient focus groups.
@en
Women's experience with severe ...... led from patient focus groups.
@nl
P2093
P2860
P356
P1476
Women's experience with severe ...... led from patient focus groups.
@en
P2093
Ariana L Smith
Catherine Sarkisian
Helen A Nissim
Jennifer T Anger
Larissa V Rodriguez
Mark S Litwin
Sally L Maliski
Shlomo Raz
P2860
P304
P356
10.1002/NAU.21004
P577
2011-04-28T00:00:00Z